Literature DB >> 28947852

Lipid lowering in renal disease.

Alice Kennard1, Richard Singer1.   

Abstract

Entities:  

Keywords:  cardiovascular disease; chronic kidney disease; dyslipidaemia; renal dialysis; statins

Year:  2017        PMID： 28947852      PMCID： PMC5601972          DOI： 10.18773/austprescr.2017.047

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  54 in total

1.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

2.  Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Authors:  Folkert W Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick de Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

3.  Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.

Authors:  N D Vaziri; K H Liang
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

4.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

5.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Authors:  Hallvard Holdaas; Bengt Fellström; Alan G Jardine; Ingar Holme; Gudrun Nyberg; Per Fauchald; Carola Grönhagen-Riska; Søren Madsen; Hans-Hellmut Neumayer; Edward Cole; Bart Maes; Patrice Ambühl; Anders G Olsson; Anders Hartmann; Dag O Solbu; Terje R Pedersen
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

6.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.

Authors:  J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

7.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

Authors:  Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

Review 8.  HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Authors:  Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Vlado Perkovic; Jorgen Hegbrant; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-05-31

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Effects of lowering LDL cholesterol on progression of kidney disease.

Authors:  Richard Haynes; David Lewis; Jonathan Emberson; Christina Reith; Lawrence Agodoa; Alan Cass; Jonathan C Craig; Dick de Zeeuw; Bo Feldt-Rasmussen; Bengt Fellström; Adeera Levin; David C Wheeler; Rob Walker; William G Herrington; Colin Baigent; Martin J Landray
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121
View more
  5 in total

1.  Lipid status association with 25-hydroxy vitamin D: Cross sectional study of end stage renal disease patients.

Authors:  Neda Milinković; Marija Sarić; Snežana Jovičić; Duško Mirković; Višnja Ležaić; Svetlana Ignjatović
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

2.  L-carnitine improves metabolic disorders and regulates apelin and apelin receptor genes expression in adipose tissue in diabetic rats.

Authors:  Neda Ranjbar Kohan; Mohammad Reza Tabandeh; Saeed Nazifi; Zahra Soleimani
Journal:  Physiol Rep       Date:  2020-12

3.  Medication Prescribing Quality in Australian Primary Care Patients with Chronic Kidney Disease.

Authors:  Woldesellassie M Bezabhe; Alex Kitsos; Timothy Saunder; Gregory M Peterson; Luke R Bereznicki; Barbara C Wimmer; Matthew Jose; Jan Radford
Journal:  J Clin Med       Date:  2020-03-13       Impact factor: 4.241

Review 4.  A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review.

Authors:  Paniz Anvarifard; Maryam Anbari; Alireza Ostadrahimi; Mohammadreza Ardalan; Zohreh Ghoreishi
Journal:  Nutr Metab (Lond)       Date:  2022-01-20       Impact factor: 4.169

5.  A Consistency Model for Identifying the Effects of n-3 and n-6 Fatty Acids on Lipoproteins in Dialysis Patients.

Authors:  Ke-Yu Chang; Yi-Chun Chen; Shu-Ching Yeh; Chih-Chin Kao; Chung-Yi Cheng; Yi-No Kang; Chih-Wei Huang
Journal:  Nutrients       Date:  2022-03-16       Impact factor: 5.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.